a clinical stage biotechnology company, which focuses on developing therapeutic products
Industry Biotechnology
A.I.dvisor tells us that BPTH and GPCR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BPTH and GPCR's prices will move in lockstep.
Ticker / NAME | Correlation To BPTH | 1D Price Change % | ||
---|---|---|---|---|
BPTH | 100% | -3.60% | ||
GPCR - BPTH | 24% Poorly correlated | -11.37% | ||
AFMD - BPTH | 24% Poorly correlated | -16.56% | ||
TRML - BPTH | 23% Poorly correlated | -9.10% | ||
XRTX - BPTH | 23% Poorly correlated | -2.61% | ||
NERV - BPTH | 22% Poorly correlated | -4.37% | ||
More |